Regulatory issues in Europe

نویسنده

  • Charlotte B Madsen
چکیده

The EU food labelling regulation tells the food producer that all ingredients in a pre-packaged product need to be in the list of ingredients. There are some exceptions from this general rule, but theses exceptions can not be used if the ingredient is a recognised allergenic food on the EU list. It is also important to note that the producer is obliged to use an easily recognisable name. As an example it is not sufficient to write casein on the list of ingredients, because consumers may not know that casein is a milk ingredient. The producer must write e.g. casein (milk). This regulation only covers pre-packaged food and not food sold loose or in restaurants. This type of food is one of the leading causes of severe allergic reactions in people. The European Council adopted in December 2010 an opinion stating that allergen information on non pre-packaged food should be ‘mandatory’. If this proposal is agreed upon by the EU parliament it will be a great advantage for food allergic persons but also a big challenge for small businesses preparing foods sold loose e.g. in bakeries or served in restaurants. Current EU legislation also has not addressed directly the issue of allergen cross contamination. Whilst there is some voluntary guidance which includes qualitative advice for industry on how to assess and manage risk from allergenic foods, there is currently no advice from regulatory bodies or compliance authorities on levels of allergen cross contamination above which advisory labelling (such as ‘May Contain Nuts’) should be used. This current absence of defined thresholds has consequences for risk managers, who have to decide what level of allergenic food in a given product constitutes a health risk and therefore requires action to manage and/or communicate the risk.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Teaching Political Science in Europe

Thisarticle first reviews the history of political science teaching in Europebefore going on to consider a range of recent developments in the teaching of politicalscience, including cross-national joint programmers; technologically enhancedlearning; placement learning and problem-based learning. The last sectionconsiders a range of issues facing political science teachers, includingfinancial p...

متن کامل

Assessing the role of regulatory bodies in managing health professional issues and errors in Europe.

OBJECTIVE This paper explores how medical regulatory bodies in nine European countries manage professional issues involving quality and patient safety, to build on limited existing information on procedures for regulating medical professionals in Europe. DESIGN Twelve vignettes describing scenarios of concerns about standards of physicians were developed, covering clinical, criminal and admin...

متن کامل

The Legal Issues of Electronic Contracts in Australia

The internet has transformed the manner of conducting commercial transactions and has created regulatory gaps. These regulatory gaps may impact the effective development of electronic commerce. Attempts are being made to regulate electronic contracts both at the national and international level. The present research analyses these attempts, in particular the Electronic Transaction Legislation ...

متن کامل

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries

Relationships between health professionals and pharmaceutical manufacturers can unduly influence clinical practice. These relationships are the focus of global transparency efforts, including in Europe. We conducted a descriptive content analysis of the transparency provisions implemented by February 2017 in nine European Union (EU) countries concerning payments to health professionals, with du...

متن کامل

Biosimilar insulins: a European perspective

Biosimilar insulins are likely to enter clinical practice in Europe in the near future. It is important that clinicians are familiar with and understand the concept of biosimilarity and how a biosimilar drug may differ from its reference product. The present article provides an overview of biosimilars, the European regulatory requirements for biosimilars and safety issues. It also summarizes th...

متن کامل

Framing Assumptions and Cyberspace Regulation: A Critical Reflection on Differences among Countries

Thispaper attempts to connect two rather different fields of study by applying concepts from regulating technological risks to the field of cyberspace regulation. The concept of framing assumption is used in order to show the cyberspace regulation differences in  countries particularly between the U.S. and the Euopean system. It shows how the U.S. and Europe have adopted different assumptions r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 1  شماره 

صفحات  -

تاریخ انتشار 2011